Towards (cost)effective cardiovascular risk management: using new drugs vs. the better use of available ones.
Shantsila
A
A
Lip
G Y H
GY
D002317:Cardiovascular Agents / Q000191:economics / Q000600:supply & distribution / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000191:economics; D003362:Cost-Benefit Analysis; D006801:Humans
D002317:Cardiovascular Agents